Technical Review of Cara Therapeutics Inc. (NASDAQ:CARA)


Technical Indicators and Signals

The stochastic oscillator indicator is the important indicator to compare the security price over a certain period of time. The stochastic %K of Cara Therapeutics Inc. (NASDAQ:CARA) for the period of 9-Day stands at 10.74% while the stochastic %D for the same period stands at 9.92%.

The 7-Day Average Directional Index ADX (also known as Trend Strength Indicator) of Cara Therapeutics Inc. (NASDAQ:CARA) signals “Sell” while other important signals like the 20-Day Moving Average Vs. Price signals “Sell”.

Another important signal of trend and momentum of a security is 20-50 Day MACD Oscillator or Moving Average Convergence Divergence signals “Sell” for Cara Therapeutics Inc. (NASDAQ:CARA) while 20-100 Day MACD Oscillator indicates “Sell”.

Bollinger band is a volatility indicator of a certain security, currently Cara Therapeutics Inc. (NASDAQ:CARA)’s 20-Day Bollinger Band indicates “Sell”.

About Company

Cara Therapeutics, Inc. is a biopharmaceutical company. The company is focused on developing and commercializing new chemical entities designed to alleviate pain. Cara Therapeutics, Inc. is based in Shelton, United States.

Previous Day Activity Analysis

On the last trading day, Cara Therapeutics Inc. (NASDAQ:CARA) opened the session at $12.82 and after going down -3.03% closed at $12.48. The stock lost -0.34 points in the last trade.

Cara Therapeutics Inc. (NASDAQ:CARA)’s stock fluctuated in the range of $12.36 and $12.98 during the previous active session. Cara Therapeutics Inc. (NASDAQ:CARA) traded with the volume of 777347 with average volume of 1.05 Million. The stock has MEDIUM volatility on the last trading session.

Currently the Beta for the company remains at 3.11 while ATR (Average True Range) and RSI (Relative Strength Index) are at 0.53 and 38.72 respectively.

Currently the Insider Ownership of the shares of Cara Therapeutics Inc. (NASDAQ:CARA) is at 3.8% and the shares outstanding are 34.15 Million.

Important Ratio Analysis

Some important ratios to consider here for Cara Therapeutics Inc. (NASDAQ:CARA) are discussed below:

Dividend yield of Cara Therapeutics Inc. (NASDAQ:CARA) stands at 0% whereas Price to Earnings P/E ratio stands at 0 while Forward P/E shows the value of 0.

The Price to Sale P/S and Price to Book P/B shows the value of 473.55 and 3.68 respectively. While Price to Cash P/C and Price to Free Cash Flow P/FCF stands at 3.79 and 0 correspondingly.

The Quick Ratio of Cara Therapeutics Inc. (NASDAQ:CARA) stands at 16.1 while the Current Ratio depicts the value of 16.1.

Return on Assets ROA of Cara Therapeutics Inc. (NASDAQ:CARA) is at -85.2% whereas, Return on Equity ROE and Return of Investment ROI of Cara Therapeutics Inc. (NASDAQ:CARA) stand at -99.6% and 0% respectively.

Stock Performance Analysis

The stock performance of Cara Therapeutics Inc. (NASDAQ:CARA) on the basis of 5 day trade show the dip of -7.07% whereas, the monthly performance of the stock shows decrease of -7.56%.

The quarterly performance of the stock remained in red zone with the value of -20.2% while six month performance of the shares of Cara Therapeutics Inc. (NASDAQ:CARA) remained bearish with the count of -27.69%.

The yearly and YTD performance of Cara Therapeutics Inc. (NASDAQ:CARA) remained up at 62.92% and 34.34% respectively.